Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.56 |
| ▸ | MPO | P05164 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | DHODH | Q02127 | 1/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.51 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.51 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.51 |
| ▸ | GNG2 | P59768 | 1/20 | 0.50 |
| ▸ | GNB1 | P62873 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL791005 | 0.99 | P2RY12 (0.60) | P2RY12ADORA2AMPOMAPTKDM4E | |
| SCHEMBL791007 | 0.99 | P2RY12 (0.60) | P2RY12ADORA2AMPOMAPTKDM4E | |
| SCHEMBL791006 | 0.89 | P2RY12 (0.54) | P2RY12ADORA2AMAPTDHODHP2RY4 | |
| SCHEMBL11593716 | 0.86 | P2RY12 (0.73) | P2RY12MAPTKDM4EMEN1USP2 | |
| SCHEMBL9116517 | 0.83 | P2RY12 (0.64) | P2RY12ADORA2AMAPTKDM4EMEN1 | |
| SCHEMBL15371383 | 0.83 | P2RY4 (0.74) | P2RY12ADORA2AMAPK1P2RY4GNG2 | |
| SCHEMBL13213994 | 0.82 | P2RY12 (0.75) | P2RY12MAPTKDM4EMEN1USP2 | |
| SCHEMBL791376 | 0.82 | P2RY4 (0.73) | P2RY12ADORA2AMAPK1P2RY4GNG2 | |
| SCHEMBL791375 | 0.80 | P2RY4 (0.75) | P2RY12P2RY4CDK2P2RY2P2RY1 | |
| SCHEMBL11413277 | 0.78 | P2RY4 (0.72) | P2RY12MAPTKDM4EMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9877940-B2 | Anthraquinone compounds and their uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2018-01-30 | — | — | US | claimed |
| US-9877940-B2 | Anthraquinone compounds and their uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2018-01-30 | — | — | US | disclosed |
| US-9877940-B2 | Anthraquinone compounds and their uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2018-01-30 | — | — | US | disclosed |
| US-9877940-B2 | Anthraquinone compounds and their uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2018-01-30 | — | — | US | disclosed |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2016-08-25 | — | — | US | disclosed |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2016-08-25 | — | — | US | disclosed |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2016-08-25 | — | — | US | disclosed |
| US-20130296588-A1 | Anthraquinone Compounds and Their Uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2013-11-07 | — | — | US | disclosed |
| US-20130296588-A1 | Anthraquinone Compounds and Their Uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2013-11-07 | — | — | US | disclosed |
| US-20130296588-A1 | Anthraquinone Compounds and Their Uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2013-11-07 | — | — | US | disclosed |
| EP-2616449-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | Dundalk Institute of Technology (IE) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012035122-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012035122-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296588-A1 | Anthraquinone Compounds and Their Uses | MYLK, CYP11B2, MYOC | P2RY12 1469/4885ADORA2A 2425/4885MPO 1737/4885 |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | MYLK, MYLK2, MYH10 | P2RY12 1864/4885ADORA2A 2678/4885MPO 1627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.